PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Clinical Pharmacologist, Pharmaceutical Department, Usl Umbria 1, A.Migliorati Street, 06132 Perugia, Italy.\', \'Clinical Pathologist, Pathologist Department, Asur Marche, A.Comandino Street, 61029 Urbino, Italy. Electronic address: raffaele.laporta@sanita.marche.it.\', \'Clinical Pathologist, Pathologist Department, Asur Marche, A.Comandino Street, 61029 Urbino, Italy.\', \'Hospital Pharmacist Manager, Pharmaceutical Department, Usl Umbria 1, A.Migliorati Street, 06132 Perugia, Italy. Electronic address: francesco.ferrara@uslumbria1.it.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0198-8859(21)00014-810.1016/j.humimm.2021.01.007
?:doi
?:hasPublicationType
?:journal
  • Human immunology
is ?:pmid of
?:pmid
?:pmid
  • 33632561
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.856
?:rankingScore_hIndex
  • 86
is ?:relation_isRelatedTo_publication of
?:title
  • Pharmacological approach for the reduction of inflammatory and prothrombotic hyperactive state in COVID-19 positive patients by acting on complement cascade.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all